Nobel Prize in Physiology or Medicine 2026 awarded for optogenetics
Karl Deisseroth, Peter Hegemann, and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine for their discoveries of light-gated ion channels and the development of optogenetics.
The Nobel Assembly at Karolinska Institutet has awarded the 2026 Nobel Prize in Physiology or Medicine jointly to Karl Deisseroth (Stanford University), Peter Hegemann (Humboldt University of Berlin), and Georg Nagel (University of Würzburg). The prize recognises their discoveries concerning light-gated ion channels — proteins called channelrhodopsins, originally identified in algae — and the development of optogenetics, the technique that uses these channels to control the activity of specific neurones with light.
Optogenetics has become a foundational tool in neuroscience research over the past two decades. By introducing channelrhodopsin genes into defined neuronal populations, researchers can activate or silence those cells with millisecond precision using targeted light pulses. The approach has transformed the study of neural circuits underlying behaviour, memory, and disease, and has opened avenues of investigation relevant to neurological and psychiatric conditions.
While optogenetics is primarily a research tool at present, early-stage clinical trials have explored its application in restoring vision in patients with inherited retinal degenerations. For genetics researchers and educators, the Nobel recognises a discovery that illustrates how characterising a non-human gene — channelrhodopsin from green algae — yielded an instrument that reshaped an entire field of biomedical science.
The prize was reported by Stat News, citing the Nobel Assembly announcement.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
The 2026 Nobel Prize in Medicine has been awarded to three scientists — Karl Deisseroth, Peter Hegemann, and Georg Nagel — for developing a technique called optogenetics. This uses proteins originally found in algae that respond to light. Scientists engineered brain cells to contain these proteins, which then allowed them to switch specific groups of brain cells on or off using flashes of light. This has become a very widely used tool for studying how the brain works. It is mainly a research technique, though scientists are exploring whether a similar approach could one day help restore some vision in people with certain inherited eye conditions. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source Stat News · 2026-10-052026 Nobel Prize in Medicine awarded for brain research tool called optogenetics